Skip to content

Clinical trials

Hypertension, Pulmonary trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension, Pulmonary Country / region: Italy Clear all

68 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20023
20031
20041
20054
20062
20072
20083
20096
20105
20112
20123
20132
20144
20152
20183
20192
20202
20216
20224
20233
20242
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed39
Terminated10
Active, not recruiting6
Recruiting6
Unknown status4
Enrolling by invitation2
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer12
United Therapeutics9
Actelion4
GlaxoSmithKline4
Eli Lilly and Company3
Insmed Incorporated3
Merck Sharp & Dohme LLC3
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.3
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA2
Gilead Sciences2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension, Pulmonary68
Pulmonary Arterial Hypertension21
Lung Diseases, Interstitial6
Familial Primary Pulmonary Hypertension5
Hypertension5
Cardiovascular Diseases4
Heart Failure4
Lung Diseases4
Pulmonary Disease, Chronic Obstructive4
Vascular Diseases4

Trials

Showing 76 to 68 of 68. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.